MedTrace Logo

Evolution of Multiple Primary Lung Cancer (Evolution)

NCT04326751 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2020-03-30

No results posted yet for this study

Summary

To investigate the evolutionary genomic landscape, explore the genetic tumor heterogeneity and microenvironment of multiple primary lung cancer (MPLC) by using tissue genetic analysis and circulating tumor DNA detection, in order to provide robust evidence for the diagnosis, treatment, and surveillance of MPLC.

Conditions

  • Multiple Primary Lung Cancers
  • Lung Cancer
  • Non Small Cell Lung Cancer

Sponsors & Collaborators

  • Guangzhou Burning Rock Medical Examination Institute Co., Ltd.

    collaborator INDUSTRY

  • Peking University People's Hospital

    lead OTHER

Principal Investigators

  • Jun Wang, M.D. · Peking University People's Hospital Thoracic Surgery Department

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2023-12-31
Completion
2023-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04326751 on ClinicalTrials.gov